Vivani Medical, Inc. (VANI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Vivani Medical, Inc. on May 13, 2026. The filing serves to announce the Company's First Quarter 2026 financial results and provide a business update. The report incorporates a press release (Exhibit 99.1) and corporate slide presentations (Exhibit 99.2) by reference.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the attached press release (Exhibit 99.1), which is incorporated by reference but not included in the text of this filing.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative financial analysis.
Guidance, Outlook, and Risks
The Company distributed slide presentations to the investment community to provide updates and summaries of its business. The filing explicitly disclaims any obligation to update these slides in the future or to reflect events occurring after the date of this report. No specific guidance, risks, or contingencies are detailed within the text of this 8-K form.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 revenue, net loss, and cash position figures.
- Examine Exhibit 99.2 (Slide Presentation) for management's business update and strategic outlook.
- Verify the Company's liquidity status and runway as detailed in the attached financial exhibits.
- Confirm any updates to product development or regulatory milestones mentioned in the press release.